Weight loss medication requires partnership between patients and providers throughout the treatment journey
Because of this, it is no surprise that drugs like semaglutide, liraglutide, and tirzepatide have gone viral. This class of drugs, with brand names like Ozempic, Wegovy, and Mounjaro, are approved to treat patients with diabetes and obesity
A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors
Eli Lilly's characterization as "generally mild" and "rarely leading to discontinuation" is reassuring but incomplete
However, oxyntomodulin requires frequent dosing owing to its very short half-life
Providers generally recommend choosing a day that is less busy so that patients can adjust to the medication and create a routine of injecting it each week